TPW
NVO

Transatlantique Private Wealth’s Novo Nordisk NVO Stock Holding History

Transatlantique Private Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$344K Buy
+6,716
New +$343K 0.11% 182
2025
Q3 		– Sell
-8,054
Closed -$556K – 226
2025
Q2 		$556K Buy
8,054
+496
+7% +$33.7K 0.2% 135
2025
Q1 		$524K Buy
7,558
+747
+11% +$61.7K 0.21% 139
2024
Q4 		$586K Buy
6,811
+640
+10% +$69.2K 0.22% 128
2024
Q3 		$734K Buy
6,171
+195
+3% +$26K 0.28% 108
2024
Q2 		$833K Sell
5,976
-433
-7% -$57.4K 0.34% 83
2024
Q1 		$822K Buy
6,409
+126
+2% +$15K 0.36% 98
2023
Q4 		$650K Buy
6,283
+267
+4% +$26.4K 0.3% 114
2023
Q3 		$547K Sell
6,016
-290
-5% -$25.5K 0.29% 113
2023
Q2 		$510K Sell
6,306
-1,264
-17% -$103K 0.27% 129
2023
Q1 		$602K Buy
7,570
+972
+15% +$68.9K 0.33% 98
2022
Q4 		$446K Buy
+6,598
New +$387K 0.27% 115

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Transatlantique Private Wealth's NVO Position: Q4 2025 in Review

Transatlantique Private Wealth opened a new position in Novo Nordisk (NVO) in Q4 2025: 6,716 shares worth $344K. The stake represents 0.11% of the portfolio and ranks #182 among its holdings. This is a return to the name: Transatlantique Private Wealth previously reported a position in NVO as recently as Q2 2025.

Transatlantique Private Wealth first reported a position in NVO in Q4 2022 and has held it in 12 quarters since. The position peaked at $833K in Q2 2024. 1,414 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Transatlantique Private Wealth held 6,716 shares of Novo Nordisk worth $344K as of Q4 2025.
  • Novo Nordisk was a new Transatlantique Private Wealth position in Q4 2025.
  • Novo Nordisk made up 0.11% of Transatlantique Private Wealth's portfolio in Q4 2025, its #182 holding.
  • Transatlantique Private Wealth first reported a position in Novo Nordisk in Q4 2022 and has held it in 12 quarters since.
  • Transatlantique Private Wealth's Novo Nordisk position peaked at $833K in Q2 2024.
  • 1,414 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.